Artiva Biotherapeutics (ARTV) EPS (Basic) (2023 - 2026)
Artiva Biotherapeutics (ARTV) posted quarterly EPS (Basic) of -$1.43 for Q1 2026, up 5.76% year-over-year from -$1.35 in Q1 2025, and down 64.59% quarter-over-quarter from -$0.87 in Q4 2025.
Powered by 
Analysis
Artiva Biotherapeutics (ARTV) EPS (Basic) (2023 - 2026) Analysis & Trends
Artiva Biotherapeutics (ARTV) has reported EPS (Basic) for 4 consecutive years, with -$1.43 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) rose 5.76% year-over-year to -$1.43; the TTM figure through Mar 2026 stood at -$4.72 (up 5.74% YoY), while the FY2025 annual figure was -$3.59, up 34.66% from the prior year.
- EPS (Basic) declined to -$1.43 in Q1 2026 per ARTV's latest filing, from -$0.87 in the prior quarter.
- Across five years, EPS (Basic) topped out at $13.92 in Q3 2023 and bottomed at -$34.58 in Q2 2024.
- Historically, EPS (Basic) has averaged -$6.37 across 4 years, with a median of -$1.65 in 2024.
- Annual changes were most pronounced in 2024 — EPS (Basic) tumbled 144.78% — and 2025, when it surged 95.64%.
- Artiva Biotherapeutics' EPS (Basic) stood at -$14.45 in 2023, then soared by 85.74% to -$2.06 in 2024, then surged by 57.96% to -$0.87 in 2025, then plunged by 64.59% to -$1.43 in 2026.
- Business Quant data shows ARTV's EPS (Basic) at -$1.43 in Q1 2026, -$0.87 in Q4 2025, and -$0.95 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.18 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.06 |
| 10 | Artiva Biotherapeutics | 441.23 Mn | 441.23 Mn | - | -0.63 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.63 |
| Mar 31, 2026 | -0.95 |
| Dec 31, 2025 | -0.85 |
| Sep 30, 2025 | -0.88 |
| Jun 30, 2025 | -0.87 |
| Mar 31, 2025 | -0.83 |
| Dec 31, 2024 | -1.43 |
| Sep 30, 2024 | -0.87 |
| Jun 30, 2024 | -19.12 |
| Mar 31, 2024 | -17.09 |
| Dec 31, 2023 | -14.19 |
| Sep 30, 2023 | 13.92 |
| Jun 30, 2023 | -14.13 |